Company: ACHV
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059297
Chunk: 7

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 7
---
 will mail without charge, upon written request, a copy of our Annual Report on Form 10-K for fiscal year ended December 31, 2024, including the consolidated financial statements, schedules and list of exhibits, and any particular exhibit specifically requested. Requests should be sent to: Achieve Life Sciences, Inc., 22722 29thDrive SE, Suite 100, Bothell, WA 98021, Attention: Corporate Secretary.

7

BOARD O F DIRECTORS General Directors are elected at each annual stockholders meeting to hold office until the next annual meeting or until their successors are elected and have qualified. Currently, there are eight members of the Board of Directors and we are nominating seven members for re-election. The following table sets forth information with respect to the directors nominated for election at the annual stockholders meeting. The ages of such persons are shown as of April 15, 2025.

| Name            |     | Age |     | Position                                                                                                  |     | Director Since |
| Stuart Duty     |     |  60 |     | Director, Chairperson of the Audit Committee and Member of the Nominating and Governance Committee        |     |           2023 |
| Thomas B. King  |     |  70 |     | Director, Interim Executive Chairman                                                                      |     |           2023 |
| Bridget Martell |     |  59 |     | Director, Chairperson of the Nominating and Governance Committee and Member of the Compensation Committee |     |           2021 |
| Nancy R. Phelan |     |  56 |     | Director, and Member of the Audit Committee and the Compensation Committee                                |     |           2025 |
| Thomas Sellig   |     |  58 |     | Director, Chairperson of the Compensation Committee and Member of the Audit Committee                     |     |           2023 |
| Kristen Slaoui  |     |  54 |     | Director and Member of the Compensation Committee and Nominating and Governance Committee                 |     |           2025 |
| Richard Stewart |     |  66 |     | Director, Chief Executive Officer                                                                         |     |           2017 |

The Board of Directors held a total of eleven meetings during fiscal year 2024. During fiscal year 2024, each of our directors attended at least 75% of the aggregate of: (i) the total number of meetings of the Board of Directors held during the period he or she was a